ArisGlobal Enables Mid-tier Biotechnology Company to Triage Inbound Adverse Event ReportsMladen Prenc2017-06-14T11:53:14+00:00June 14, 2017|Read More
PPD and ArisGlobal | A Pharmacovigilance Success StoryMladen Prenc2017-06-14T09:43:00+00:00June 14, 2017|Read More
Removing the Pain Points from Overburdened Medical Affairs TeamsMladen Prenc2017-06-13T12:44:31+00:00June 13, 2017|Read More
Enabling an Evidence-Based Approach to Pharmacovigilance and SafetyMladen Prenc2017-05-31T05:30:53+00:00May 31, 2017|Read More
The Search for Simplicity, Scalability and Timely Insights in Regulatory AffairsMladen Prenc2017-05-24T04:43:38+00:00May 24, 2017|Read More
Automation in Pharmacovigilance Data Processing – Do You Trust Artificial Intelligence?Mladen Prenc2017-05-16T02:52:09+00:00May 16, 2017|Read More
ArisGlobal Viewpoint: How Digitization Changes the Role of Regulatory AffairsMladen Prenc2017-04-24T06:50:54+00:00April 24, 2017|Read More
ArisGlobal Expert Shares How Regulatory Affairs Needs to Adapt to Transformation ChangeMladen Prenc2017-04-17T04:20:20+00:00April 17, 2017|Read More
Think Big: Regulatory Affairs Must Prepare to Respond to Strategic Business DriversMladen Prenc2017-04-10T04:50:57+00:00April 10, 2017|Read More
A Secret Weapon to Act on Your IDMP AssessmentMladen Prenc2017-04-05T06:50:34+00:00April 5, 2017|Read More
Drug Adverse Event Reporting Software is Now Mobile-FriendlyMladen Prenc2017-03-22T08:38:29+00:00March 22, 2017|Read More
New Rules Propose Challenges in Medical Affairs and PharmacovigilanceMladen Prenc2017-03-21T09:00:11+00:00March 21, 2017|Read More
